HomeTOP STORIESLisata Therapeutics to be acquired by Kuva Labs in $4.00-per-share cash deal Lisata Therapeutics to be acquired by Kuva Labs in $4.00-per-share cash deal By rogerjudd January 21, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleForecasters Warn of a Major Storm Brewing for the SouthNext articlePrologis FFO of $1.44 in-line, revenue of $2.25B beats by $160M latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
